BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35073986)

  • 21. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistant starch supplementation effects on plasma indole 3-acetic acid and aryl hydrocarbon receptor mRNA expression in hemodialysis patients: Randomized, double blind and controlled clinical trial.
    Azevedo R; Esgalhado M; Kemp JA; Regis B; Cardozo LF; Nakao LS; Brito JS; Mafra D
    J Bras Nefrol; 2020; 42(3):273-279. PubMed ID: 32459282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary strategies for gut-derived protein-bound uremic toxins and cardio-metabolic risk factors in chronic kidney disease: A focus on dietary fibers.
    Melekoglu E; Samur FG
    Crit Rev Food Sci Nutr; 2023; 63(19):3994-4008. PubMed ID: 34704501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cranberry supplementation on toxins produced by the gut microbiota in chronic kidney disease patients: A pilot randomized placebo-controlled trial.
    Teixeira KTR; Moreira LSG; Borges NA; Brum I; de Paiva BR; Alvarenga L; Nakao LS; Leal VO; Carraro-Eduardo JC; Rodrigues SD; Lima JD; Ribeiro-Alves M; Mafra D
    Clin Nutr ESPEN; 2022 Feb; 47():63-69. PubMed ID: 35063244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats.
    Kieffer DA; Piccolo BD; Vaziri ND; Liu S; Lau WL; Khazaeli M; Nazertehrani S; Moore ME; Marco ML; Martin RJ; Adams SH
    Am J Physiol Renal Physiol; 2016 May; 310(9):F857-71. PubMed ID: 26841824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feeding cats with chronic kidney disease food supplemented with betaine and prebiotics increases total body mass and reduces uremic toxins.
    Hall JA; Jewell DE; Ephraim E
    PLoS One; 2022; 17(5):e0268624. PubMed ID: 35609046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effects of Resistant Starch Consumption in Adult Patients With Chronic Kidney Disease: A Systematic Review.
    Kingra K; Curtis S; Mollard RC; Shamloo M; Askin N; Tangri N; MacKay D
    Can J Kidney Health Dis; 2022; 9():20543581221100023. PubMed ID: 35847176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial.
    Rossi M; Johnson DW; Morrison M; Pascoe E; Coombes JS; Forbes JM; McWhinney BC; Ungerer JP; Dimeski G; Campbell KL
    BMC Nephrol; 2014 Jul; 15():106. PubMed ID: 24996842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Poesen R; Evenepoel P; de Loor H; Delcour JA; Courtin CM; Kuypers D; Augustijns P; Verbeke K; Meijers B
    PLoS One; 2016; 11(4):e0153893. PubMed ID: 27100399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress.
    Margiotta E; Caldiroli L; Callegari ML; Miragoli F; Zanoni F; Armelloni S; Rizzo V; Messa P; Vettoretti S
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Resveratrol Supplementation Reduce Uremic Toxin Plasma Levels From the Gut Microbiota in Nondialyzed Patients With Chronic Kidney Disease?
    Alvarenga L; Cardozo LFMF; Leal VO; Kemp JA; Saldanha JF; Ribeiro-Alves M; Meireles T; Nakao LS; Mafra D
    J Ren Nutr; 2022 Nov; 32(6):685-691. PubMed ID: 35122992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
    Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diet Quality and Protein-Bound Uraemic Toxins: Investigation of Novel Risk Factors and the Role of Microbiome in Chronic Kidney Disease.
    McFarlane C; Krishnasamy R; Stanton T; Savill E; Snelson M; Mihala G; Morrison M; Johnson DW; Campbell KL
    J Ren Nutr; 2022 Sep; 32(5):542-551. PubMed ID: 34776340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzobiotics-A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial.
    Saxena A; Srinivasa S; Veerappan I; Jacob C; Mahaldar A; Gupta A; Rajagopal A
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uremic toxins levels from the gut microbiota seem not to be altered by physical exercise in hemodialysis patients.
    de Brito JS; Vargas D; da Silva GS; Marinho S; Borges NA; Cardozo LFMF; Fonseca L; Ribeiro M; Chermut TR; Moura M; Regis B; Meireles T; Nakao LS; Mafra D
    Int Urol Nephrol; 2022 Mar; 54(3):687-693. PubMed ID: 34254218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    McFarlane C; Ramos CI; Johnson DW; Campbell KL
    J Ren Nutr; 2019 May; 29(3):209-220. PubMed ID: 30366767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease.
    Melekoglu E; Cetinkaya MA; Kepekci-Tekkeli SE; Kul O; Samur G
    PLoS One; 2021; 16(10):e0258145. PubMed ID: 34614017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study).
    Marzocco S; Fazeli G; Di Micco L; Autore G; Adesso S; Dal Piaz F; Heidland A; Di Iorio B
    J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30274359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.